4% Huada Genomics: Shareholders intend to inquire about transferring 4% of the company's shares.

BGI Genomics announced that its shareholder, Shenzhen BGI Genomics Technology Co., Ltd., plans to transfer 16.73 million shares of the company through inquiry-based transfer method, accounting for 4.00% of the company's total share capital. The reason for this transfer is due to the capital needs of BGI Holding, mainly to support the incubation of cutting-edge technologies in the field of new qualitative productivity.